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Abstract

DELAY TO HOSPITAL ARRIVAL AFTER ACUTE MYOCARDIAL
INFARCTION IN A POPULATION-BASED SAMPLE OF ELDERLY
PERSONS. John P. Sverha, Laura V. Vaccarino, Harlan M. Krumholz.
Section of Cardiology, Department of Internal Medicine, Yale University,
School of Medicine, New Haven, CT.

The purpose of this study was to determine 1) if measures of social isolation,
cognitive function, and functional ability are associated with prolonged delay
to hospital arrival (> 6 hours) in elderly persons with acute myocardial
infarction (AMI) and 2) whether prolonged delay in elderly persons with
AMI is an independent predictor of mortality. The study sample comprised
183 persons aged 65 years or older from the New Haven cohort of the
Established Populations for Epidemiologic Studies of the Elderly program
who had experienced a myocardial infarction between the years 1982 and 1992
and for whom data describing delay time from symptom onset to hospital
arrival was available. Information describing sociodemographic factors and
past medical history were collected at annual interviews preceeding the
myocardial infarction.

Information describing clinical presentation,

thrombolytic use, and hospital course following AMI was collected by chart
review. The relationship between prolonged delay and social isolation,
cognitive ability, and functional ability was examined by univariate and
multivariate analysis. The effect of prolonged delay time on inhospita!
complications, 30-day mortality, and 1-year mortality was examined by
univariate analysis and also by multivariate analysis while controlling for
usual predictors of mortality after AMI. Prolonged delay was found to be

independently associated with lower Killip class, older age, absence of home
visitation by a health care worker, and lower educational level (pc.05).
Prolonged delay was also found to be associated with significantly elevated 30day (16% vs. 29%) and 1-year mortality (35% vs. 50%) in both univariate and
multivariate analyses.

The principal finding of this study is that measures of

social isolation, cognitive function, and functional ability were unable to
predict prolonged delay in elderly persons with AMI. An additional finding
is that delay time was an independent predictor of mortality in elderly
persons with AMI.
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Introduction

1.25 million Americans suffer a heart attack each year, of whom
approximately 500,000 die as a result (1). Death from acute myocardial infarction
(AMI) is the single most common way to die in America today, causing about
one-fourth of all deaths each year (2).
The prevalence of death due to AMI is disheartening considering the progress
which has been made in the management of myocardial infarction. While
bedrest was the standard of care for AMI as recently as the 1950's, it is now
possible to correct arrythmias, limit infarct size, and even reperfuse the
myocardium. As efforts continue to develop novel treatments for AMI,
increasing attention is now being directed toward ways to maximize the benefits
of current interventions. An important means of improving the effectiveness of
today's therapies is by decreasing the time interval from the onset of symptoms
to their administration. This understanding has prompted efforts to quantify the
benefits of early treatment and to explain why delay to treatment occurs.
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Benefit of Early Treatment After Acute Myocardial Infarction

The potential benefit of early treatment after AMI is great as it is soon after
myocardial infarction that much of the mortality occurs. In a careful study
conducted in 1967 by Armstrong et al., it was found that 51% of deaths caused by
AMI occured within the first 2 hours and that 74% of deaths occured within the
first 24 hours (4). Similar results have been reported by other authors (5,6,7).
Modem cardiac care, if delivered promptly, can prevent many of the deaths
which occur soon after AMI. Perhaps the most important intervention to have
available early after AMI is defibrillation. The significance of defibrillation lies in
the fact that it is an excellent means of treating the most common cause of death
early after AMI, ventricular fibrillation (8). It is estimated that 85% of ventricular
fibrillation is corrected by a single countershock of 200J (9). However, prognosis
following defibrillation is very dependent on the rapidity with which the
countershock is administered. In a study conducted by Weaver et al. which
followed the outcomes of 942 patients who were resuscitated after out of hospital
ventricular fibrillation, 37% of patients survived to be discharged when
defibrillation occurred within three minutes of ventricular fibrillation compared
to 14% if defibrillation occurred after ten minutes (10).
Seeking medical attention after symptoms of AMI develop allows prompt
defibrillation if ventricular fibrillation does occur. This care should be sought
immediately as it is soon after AMI that most episodes of ventricular fibrillation
occur. In a study Pantridge et al. of 294 patients with AMI, 55 patients were seen
to develop ventricular fibrillation within 12 hours of AMI. 41 of these patients
(75%) developed ventricular fibrillation within the first two hours (11).
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Other therapies which have been shown to improve outcome if applied early
after AMI include nitroglycerin, beta-blockers, and aspirin. Precisely how early
after myocardial infarction these medications must be given for maximal benefit
is not clear. However, the pooled results of six studies of nitroglycerin in which
it was given on hospital arrival to persons with AMI and chest pain showed an
average mortality reduction of 33% (12). Other studies have shown beta-blocker
therapy to reduce one-week mortality by 13% if started within 12 hours of
hospital arrival (13) and aspirin therapy to reduce 5-week mortality by 23% if
given within 24 hours of hospital arrival (14).
Thrombolytic therapy is the intervention most often cited today as the chief
reason to seek prompt medical attention after AMI. It has consistently been
shown that the benefits of thrombolytic therapy are dependent on how soon it is
administered after AMI. A recent meta-analysis of the nine largest randomised
clinical trials of thrombolytic therapy shows a linear decrease in the reduction of
35-day mortality after AMI with delay time to thrombolytic administration. The
mean mortality reduction was 27% if thrombolytics were given within the first
hour, 16% if given within four to six hours, and a statistically insignificant 5% if
given in 13-24 hours (17). The current guidelines issued by the American
College of Cardiology and the American Heart Association recommend that
thrombolytics should generally not be given more than 6 hours after myocardial
infarction (18). It is thought that by this time the benefits of thrombolysis have
dwindled such that they are outweighed by the medication's side effects.
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Delay After Acute Myocardial Infarction

Research aimed at determining the time from symptom onset to hospital
arrival began in the late 1960's. This initial interest in length of delay paralleled
the development of defibrillation, the use of mobile intensive care units, and a
growing realization that early care after AMI could save lives. A second surge of
interest in delay time began in the late 1980's with the advent of thrombolytic
therapy and has continued into the present.

Length of Delay
The median delay time reported in most studies is in the range of 2-3 hours,
although median delay times of up to 6.5 hours have been reported (19-42)(Table
1). Mean delay time is longer than median delay time in all studies with no
study reporting a mean delay time of less than 4 hours. The difference between
median and mean delay times is due to the skewing effect caused by the few
individuals who wait many hours or even days before seeking medical care for
their AMI. When delay time is presented in an alternative manner, the
percentage of patients delaying >6 hours has been found to be between 21 % and
37% (47,48).
Variability in the delay times reported by previous authors can be partly
explained by differences in the populations studied and differences in their
inclusion criteria. As seen in table 1, study populations differed widely
according to age, gender, and race. In addition, some studies granted eligibility
to those with suspected AMI while other studies were confined to those with
verified AMI.
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Phases of Delay
Delay time has typically been defined as the amount of time between an
individual's first awareness of symptoms and arrival of the individual at the
hospital. Given the emergence of new therapies for AMI, it is now more
appropriate to speak of total delay time which is the interval from the onset of
symptoms to the initiation of definitive therapy, such as thrombolytics.
Total delay time can be understood as being composed of three separate
phases: patient decision time, prehospital time, and hospital time. The patient

decision time encompasses the interval from when the patient first begins to
experience symptoms until the patient decides to go to the hospital. The

prehospital time is defined as the amount of time between the activation of the
emergency response system (i.e. dialing 911) and arrival at the hospital or,
alternatively, the amount of time it takes for the patient himself to travel to the
hospital. The hospital time encompasses the interval between arriving at the
hospital and the initiation of definitive care.
Research into the respective contribution of each of the three phases to total
delay time has consistently shown that patient decision time is the most
significant cause of delay. Direct estimates of its contribution to total delay time
range from 50-65% (25,28,42). This correlates well with the fact that mean delay
times are greater than 4 hours while prehospital time averages 7-22 minutes
(32,36,42) and hospital time averages 60-90 minutes (49,50).

Variables Affecting Total Delay Time
The extent to which total delay time is determined by the patient decision
phase is reflected in the variables which have been associated with total delay
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time. The following is a summary of how various variables affect total delay
time as reported in the literature.

Sociodemographic Variables (Table 2)
Age - Older age is probably correlated with increased delay time. A total of 16
studies have examined the relationship between age and delay with 8 of the
studies showing age to prolong delay. The remaining 8 studies demonstrated no
correlation between age and delay. The study with the largest sample size (3,256
participants, 1823 >65 years old) was conducted by Weaver et al. using registry
data from Seattle, WA and showed that while median delay times did not
increase with age, mean delay times rose form 4.1 hours to 6.1 hours (24). A
more recent study by Yarzebski et al. involving 1279 patients showed that
patients older than 75 were significantly more likely to delay >2 hours than
younger patients (21). Median delay times were found to vary with age in a
study by Turi et al. in 1986 which utilized data from the Multicenter
Investigation of Limitation of Infarct Size (MILIS) trial (34). In this study,
patients <55 years old presented at 2.7 hours compared with 3.3 hours for those
over the age of 55. The largest study to conclude that age has no effect on delay
times was conducted by Alonzo (35). However, Alonzo examined the effect of
age on several individual phases of total delay time, making it difficult to
compare his results with those of other studies.
Gender - Gender has been shown to have no effect on delay times in 10 of the
14 studies in which it was examined. In the four studies which showed a
significant relationship between gender and delay time, female gender was
associated with a slight increase in delay (25,34,35,43). For example, Turi et al.
reported a median delay of 3.2 hours for women compared to 3.0 hours in men
(34).
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Race - Most delay time research has been conducted on populations that are
entirely Caucasian or have contained such a small percentage of minority
patients as to make their results difficult to interpret. There have been 2 studies,
however, which have been conducted exclusively with black patients. The first
study, performed by Cooper et al., involved 111 patients admitted to a municipal
hospital in Chicago. These patients showed a remarkably long median delay
time of over 6 hours (33). A more recent study by Ell et al. involving 448 black
patients in Los Angeles found a median delay of 2.65 hours, which is similar to
that seen in Caucasian populations (20).
Education - Level of formal education acheived was not associated with delay
time in 5 of the 6 studies in which it was examined (20,32,38,40,43). In the single
study in which an effect was noted, low educational level was found to increase
delay time (42).
Socioeconomic status - Most studies have concluded that socioeconomic status
does not effect delay time (20,32,38). An exception is a study conducted by
Schmidt et al. which found low income one of several variables associated with
prolonged delay in a multivariate analysis (25).

Past Medical History (Table 3)

Many patients who present with symptoms of AMI have a past medical
history which includes angina, diabetes, hypertension, congestive heart failure,
or even previous MI. It is often assumed that patients with these risk factors
would be less likely to delay in seeking care due to their presumed familiarity
with the medical system and the symptoms of myocardial infarction. A striking
finding which persists across virtually all studies is that past medical history,
even the history of a previous MI, does not affect delay time. Some authors have
suggested that prior experience with the symptoms of AMI causes patients to be
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less alarmed by their presence and results in a greater willingness to delay
seeking care in the hope that symptoms will resolve. The few studies which have
found an association between past medical history and delay time suggest that a
history of diabetes or chronic angina may prolong delay time slightly
(21.25.34.40) .

Circumstances of Myocardial Infarction (Table 4)
Several authors have investigated the effect of the timing of the myocardial
infarction and the location of the patient when the myocardial infarction occured.
Most authors have found that being alone at the time of AMI reduces delay time,
perhaps because consultation with others tends to prolong delay (41,42,44).
Studies examining the time of day the AMI occurred, whether it occurred on a
weekend, or whether the patient was at home at the time of the MI have
produced inconsistent results (21,32,40,42).

Symptoms of Myocardial Infarction (Table 5)
Several studies of delay time have recorded the frequency with which AMI
was accompanied by chest pain with the results ranging from 64 to 91 %
(25.29.40) . It has been suggested that atypical presentations of myocardial
infarction (i.e. without chest pain) and the resulting confusion as to the cause of
the pain may cause some persons to delay in seeking medical attention.
However, no relationship between the prevalence of chest pain and delay time
has been found in any study to date. The severity of chest pain has been linked to
shortened delay times in the three studies in which it was examined (20,25,41).
In the single study which examined the rate of symptom progression, it was
found that a slow progression of symptoms was associated with longer delay
(25).
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Severity of Myocardial Infarction (Table 6)
Hemodynamic instability has been shown to shorten delay time in all studies
in which it has been examined (23,29,34). Typically, this has been measured as
either a low presenting systolic blood pressure or a higher Killip class. The size
of infarct as reflected by peak creatine phosphate kinase enzyme level has been
been examined in two studies, with that by Schmidt et al. showing decreased
delay with larger infarct size (25,28). The distinction between Q wave and non-Q
wave MI has generally not been helpful in predicting delay except in the study
by Turi et al. in which Q wave MI was associated with a slight decrease in
median delay time from 3.3 to 3.0 hours (34).

Medical Sophistication (Table 7)
The understanding that one's symptoms are cardiac in nature has been
associated with shorter delay times in three of four studies (22,25,26,41).
Knowledge of thrombolytic therapy and the benefits of early treatment were
associated with decreased delay in one of two studies (22,25).
There have been several studies which have examined the effectiveness of
mass education campaigns designed to reduce patient delay time after AMI. The
results of the first investigation of this kind were published by Mitic et al. in 1984
(46). In this study, a population of 300,000 in Nova Scotia was exposed to an
eight week campaign utilizing TV, radio, and newspaper messages to describe
the symptoms of AMI and the importance of early treatment. As a consequence
of this campaign, the percentage of patients presenting in <2 hours rose
significantly, from 15.8% to 29.3%.
More recent studies of the effectiveness of mass education efforts have been
less encouraging. A media campaign similar to that in Nova Scotia was

I
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conducted in Seattle, WA in 1986 (27). In this case, delay time was not
significantly reduced. In addition, the proportion of persons who presented to
the emergency department with chest pain who were confirmed to have a
myocardial infarction decreased from 34% to 25%. The authors warned of an
increase in emergency department visits for non-cardiac chest pain and stable
angina as a possible drawback of future mass education campaigns.
The most recent educational campaign aimed at reducing delay time was
conducted in Goteburg, Sweden in 1987. Blohm et al. report that although
median delay times were successfully reduced from 3.0 to 2.3 hours with no
decrease in the percentage of confirmed AMI's, the mortality rate for patients
presenting with AMI was not affected (45).

Patient Actions After Onset of Symptoms (Table 8)

Alonzo has reported that 93% of persons contact someone before proceeding
to the hospital with AMI and that consulting a family member is most likely to
prolong delay. He suggests this may be due to a shared motivation on the part of
the family member to deny the seriousness of the event (44). Other authors have
noted that contacting one's physician leads to increased delay time
(22,25,28,32,44). This is thought to be due to both the frequent difficulty in
actually contacting the physician and the occasional advice on the part of the
physician to continue to observe the symptoms without going to the hospital.
Still other authors have reported that self-medication after onset of symptoms is
strongly related to prolonged delay (20,34,36,38,44).

Coping Mechanism

The means by which one copes with a sudden change of health status surely
affects the length of decision time after AMI. Several authors have investigated
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the influence of denial on delay times and have found no effect (25,32,41).
However, these studies are hampered by the methodological problems of
assessing denial retrospectively and the absence of an appropriate psychometric
instrument (51).

Developing a Model of Patient Decision-Making After AMI
The decision to seek care after AMI is obviously complex and seems to be
affected by a diversity of factors including sociodemographic variables, the
nature of the symptoms, the interpretation of the symptoms by the patient, and
consultation with others. In order to better understand why persons seek care
after AMI, the National Heart Attack Alert Program Coordinating Committee
has proposed a model of patient-decision making during AMI. In developing
this model, the committee drew upon two existing decision-making models used
in patient compliance research: the health belief model and the symbolic
interactionism model. The focus of the health belief model is an individual's
cognitive response to a perceived health threat and the resulting cost-benefit
analysis of possible responses to this information. The symbolic interactionism
model emphasizes the importance of social interactions in making health-related
decisions. It also acknowledges that an individual's personality (or "selfconcept") effects the process. Below is a diagram of the proposed "integrated"
model of patient decision-making after AMI (Figure 1).
The value of this model is in providing a hypothesis as to how the multiple
factors shown known to influence patient delay time may interact. While it is
important to know whether sociodemographic factors, past medical history, or
clinical presentation are associated with delay time, it is even more useful to
understand why or how these variables affect delay. It is only with this
knowledge that logical interventions to reduce delay can be designed.

Figure 1. An Integrated Model of Patient Decision-Making After AMI
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Effect of Delay Time on Prognosis After AMI
While the impact of delay time on mortality has been well established for
persons who receive thrombolytics after AMI, the relationship between delay
time and prognosis in populations in which only a fraction of persons receive
thrombolytics is less dear. Several studies of the effect of delay time on
prognosis conducted before the advent of thrombolysis have found increased
mortality in those patients with longer delay times (34,33,40), although other
authors have conduded that delay time has no effect on mortality (38,21,60,61)
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The inconsistent effect of delay time on prognosis when thrombolytics are
only occasionally used can be explained by the fact that delay time is influenced
by many of the same factors that affect survival after AMI. Hemodynamic
instability after AMI and size of infarct are both indicators of poor prognosis yet
are strongly associated with shorter delay times (34,23,29,28). Older age, female
gender, black race, and diabetes are also predictors of poor prognosis after AMI,
yet have been associated with longer delay times (24,34,40,29,25,31,35,20,21).
Any effort to determine the true effect of delay time on prognosis after AMI in
the absence of thrombolysis must control for as many of the covariables
described above as possible. To our knowledge, there have been only 4 previous
studies which have attempted multivariate analyses (59,23,29,34) (Table 9).
Three of these studies found no significant independent effect of delay time on
prognosis although the studies conducted by Turi et al. and Cragg et al. did not
control for the level of hemodynamic instability after myocardial infarction
(59,34). One study, conducted by Logue et al., did find that delay time affected
prognosis. He reported that persons who arrived in <1.5 hours experience
increased inhospital mortality (23).
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Purpose of Study

Among the many factors which affect delay time after AMI, the association
between older age and prolonged delay is particularly important. The finding
that the elderly delay longer after AMI than younger persons is concerning for
several reasons including:

1) The elderly represent an expanding segment of the population. Persons aged
65 or older currently number over 30 million in the United States and are
expected to increase by 6 million over the next decade. This age group is
the fastest growing segment of the population and is expected to
comprise greater than 20% of the entire population by the year 2030 (52).
2) The elderly are at a higher risk for AMI than younger persons. Current
estimates are that 60% of the hospitalizations for AMI are in persons
older than 65 (53).
3) Increasingly aggressive early treatment of AMI is now being recommended for
the elderly. Recent appreciation of the particularly poor prognosis of

elderly who are not offered aggressive therapy has resulted in a
reevaluation of conservative treatment strategies (54). This is best
exemplified by the debate regarding the use of thrombolytic therapy in
the elderly. Consensus is now emerging that thrombolytic therapy
should not be denied to any patient on the basis of age alone (48).

The reasons why the elderly are more likely than younger persons to delay
after AMI are not clear. An understanding as to why the elderly are particularly
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prone to delay would be helpful in identifying elderly who are at especially high
risk for delay and for designing interventions to reduce delay in this population.

Study Hypotheses
This study tests the hypothesis that prolonged delay in elderly persons with
AMI can partly be explained by increased social isolation, cognitive impairment,
and functional disability in this population. Social isolation may cause elderly
persons to be more hesitant in contacting others for help. Cognitive impairment
may make it difficult to recognize the cause of one's symptoms or the neccessity
of seeking help. Functional disability may physically prevent a person from
seeking help. Each of these variables is unique to this study, having never been
examined in previous studies of patient delay after AMI.
An additional hypothesis is that prolonged delay to hospital arrival is an
independent predictor of mortality in elderly persons with AMI. Previous
studies examining the effect of delay time on prognosis have produced
inconsistent results as they have often failed to control for usual predictors of
mortality after AMI.
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Methods

Study design
The study sample comprised patients from the New Haven cohort of the
Established Populations for the Epidemiologic Study of the Elderly (EPESE)
program. This program was initiated in 1980 by the National Institute of Aging
with the goal of studying risk factors for chronic disease and disability in the
elderly. The program consists of four epidemiologic cohort studies in four
separate locations: New Haven, CT; East Boston, MA; Washington and Iowa
Counties, Iowa; and Durham, NC.
The New Haven cohort of EPESE, known as the Yale Health and Aging Project
(YHAP), was established in 1982 as a longitudinal, community-based cohort
study of 2,812 persons aged 65 years or older living in New Haven. The sample
was stratified by housing type so that the cohort consisted of 26% who lived in
public housing for the elderly, 31% who lived in private housing for the elderly,
and 43% who lived in private houses or apartments. The population was
oversampled for men so that the cohort would have equal numbers of men and
women. The cohort is heterogeneous regarding ethnic, racial, and social
backgrounds (58).
Since assembling the cohort, participants have been interviewed yearly
regarding their health status, medication use, and functional status. The initial
contact in 1982 as well as recontacts in 1985 and 1988 were conducted by face-toface interview. All other annual contacts were made by telephone interview.
Information regarding hospitalizations and deaths came from the annual
interviews with additional surveillance provided by obituary notices, hospital
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records, proxy information, and the National Death Clearance. To date, less than
one percent of the cohort has been lost to follow-up.
The subjects in this study represent persons from the New Haven cohort of
EPESE who were hospitalized for myocardial infarction between the years 1982
to 1992. These patients were identified by weekly monitoring of two New Haven
hospitals (Yale-New Haven Hospital and The Hospital of St. Raphael's) where it
had previously been determined that 90-95% of YHAP participants were
hospitalized for AMI. The medical records were requested for those participants
who had a discharge diagnosis of AMI (ICD-9-CM codes 410.0-410.9) or unstable
angina (ICD-9-CM codes 411.1 and 411.8). Patients were eligible for our study
only if a myocardial infarction was verified to have occurred within 48 hours of
admission and was clearly not triggered by surgery or trauma. Two of the
following three criteria had to be present for AMI to be confirmed:

1) Central anterior chest pain lasting at least 15 minutes or acute pulmonary
edema or cardiogenic shock
2) Pathological q waves (>.04 seconds) or ST elevation followed by T wave
inversion in at least two leads
3) Serum creatine phosphate kinase MB fraction (CPK-MB) increased to
greater than 4%

A total of 229 YHAP participants were confirmed by the criteria above to
have had a myocardial infarction. Data describing the delay to hospital arrival
was available for 183 of these 229 patients. The inpatient charts of the 183
patients were reviewed and information describing clinical presentation,

thrombolytic use, and inhospital complications was abstracted with the aid of a
form designed for this purpose.
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Definition of Delay Time
Delay time in this study was defined as the time interval between symptom
onset and arrival at the hospital. Delay times were classified as being less than or
greater than six hours. This time interval was chosen as it is the most often cited
time restriction for the use of thrombolytic therapy.

Description of Delay Time Variables
A description of delay time variables is provided below. For those variables
which were assessed at more than one interview, the data collected at the most
recent interview preceding the myocardial infarction was used.

Sociodemographic variables
Age - Age was measured at the time of hospitalization for myocardial infarction.
Patients were classified into two groups based on whether they were
between the ages of 65 and 74 or 75 years and older.

Race - Race was assessed by asking the study participants which group described
their racial background. The race variable was analyzed as either black or
non-black.

Education - The number of years of regular school completed was recorded as
being greater than or less than 12 years.

Medical History Variables
Previous myocardial infarction - A previous myocardial infarction was considered
to have occurred if it was recorded in the patient's past medical history
when admitted for AMI. Presence of old Q waves on the admission ECG
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without a history of infarction was not considered sufficient to qualify for
prior infarction.
Chronic angina pectoris - This was considered to be present when a history of
stable angina was recorded in the admission note for AMI. Recent onset
angina (i.e. less than one week prior to admission for AMI) was not
considered to be chronic angina pectoris.
Hypertension - Subjects were considered to have hypertension if either a history of
high blood pressure was recorded on admission for AMI or, according to
the YHAP interview preceding admission, the patient was taking
medications for high blood pressure.
Diabetes mellitus - A patient was classified as having diabetes mellitus if history of
diabetes was recorded in the admission note for AMI or if the patient was
taking insulin or oral hypoglycemic medications prior to AMI.
Previous congestive heart failure - A history of congestive heart failure was
recorded if such a diagnosis was stated in the admission note for AMI, or if
the patient was taking digitalis before admission in the absence of a history
of atrial fibrillation.
Smoking - A distinction was made between current smokers at the time of AMI
and those who had smoked in the past. Only the influence of current
smoking on delay time was examined.
Body mass index - The weight and height values reported by the participants at the
YHAP interview preceding the myocardial infarction were used to compute
the body mass index according to the following formula: body mass index
= weight(kg) / height(m)2. For our analysis, body mass index was divided
into three categories: <23 (underweight), 24-28 (acceptable or overweight),
and 29+ (obese).
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Previous cerebrovascular accident - This information was derived from the
admission note at the time of myocardial infarction.

Clinical Presentation Variables
Systolic blood pressure - This was measured during the admission exam for AMI
with the patients being divided into tertiles on the basis of its magnitude.

Killip class - Hemodynamic status after myocardial infarction was measured
according to the traditional Killip classification described below:
I - no failure
II - heart failure; defined by the presence of rales in the inferior half of the
pulmonary fields in the admission exam or moderate pulmonary edema
on chest X-ray
III - frank pulmonary edema; defined by rales beyond the inferior half of
the pulmonary fields or full pulmonary edema on chest X-ray
IV - cardiogenic shock; defined by systolic blood pressure <90 on
admission

Presence of chest pain - Presence of chest pain during the admission exam for AMI
or immediately prior to admission was noted.

Peak CPK greater than four times the uppermost limit of normal- This criteria was
used to identify particularly large infarcts.

Conduction disorder on admission - A conduction disorder was diagnosed in the
presence of either left bundle branch block or atrio-ventricular block (either
second degree Mobitz type II or third degree) in any of the first three
electrocardiograms within 48 hours of admission.

Atrial fibrillation on admission - The presence of atrial fibrillation in any
electrocardiogram performed within 48 hours of admission was noted.

Type of myocardial infarction - Three categories were considered:
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1) Q wave MI - new pathologic Q waves (>.04 seconds) on the ECG
accompanied by either typical chest pain or CPK-MB >4%
2) non-Q wave MI - CPK-MB >4% accompanied by either typical chest pain
or ST-segment changes without the development of pathologic Q waves
3) indeterminate - typical chest pain or CPK-MB elevations in the presence
of left bundle branch block, paced rhythm, or other conditions which
make the interpretation of Q waves difficult

Social Isolation Variables

Social ties - A summary measure of social ties was constructed to indicate the
number of four different categories of ties:
1) presence of a spouse
2) reported contact with two or more close friends and/or relatives
3) regular church attendance (at least once per month)
4) membership in other types of groups
Scores from this summary measure were determined by counting the
number of different categories of social ties present (0,1,2,3+.)

Living alone - Participants were asked how many persons resided in their
household at each annual interview.

Cognitive Function Variables

Cognitive function - A series of seven questions testing orientation, memory, and
concentration were asked during face-to-face interviews. A person was
considered cognitively impaired for the purposes of this study if they
answered three or more of these questions incorrectly.

Dementia - A history of dementia was recorded only if it was described in the
admission note for AMI.
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Functional Ability Variables

Functional disability- This variable was measured by a series of six questions in
which participants were asked at the time of the interview whether they
needed help walking, bathing, dressing, eating, rising from a chair, or using
the toilet. Participants were grouped into three categories based on whether
they where unable to independently perform zero, one, or two or more of
the activities of daily living listed above.

Home care worker visitation - Participants were asked if any health care worker
visited their home on a regular basis to help take care of them.

Description of Outcome Measures
The outcome measures in this study included inhospital complications, 30-day
mortality, and one-year mortality. The inhospital complications examined were
recurrent chest pain, recurrent ischemia, reinfarction, and congestive heart failure
after admission. They were defined as follows:

Recurrent chest pain- Any episode of typical anterior chest pain which occurred
after the original episode of chest pain and was not accompanied by ECG
modifications indicative of ischemia or CPK-MB elevations above the
normal limit.

Recurrent ischemia- ECG modifications indicative of new ischemia which occured
more than 48 hours after admission and were not accompanied by CPK-MB
elevations.

Reinfarction - Defined by the same criteria as the initial myocardial infarction
although this myocardial infarction was required to have occurred at least
48 hours after admission.

I

I
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Congestive heart failure after admission - Determined by increased rales on
auscultation, new S3 gallup, or chest X-ray modifications compared with the
admission exam or chest X-ray.

Statistical Analysis
To determine if early (<6 hours) and late (>6 hours) arrival groups differed
significantly regarding sociodemographic factors, past medical history, or clinical
presentation, a univariate analysis was performed. The chi-square test was used
for categorical variables and the Mantel-Haenszel chi-square test was used for
interval-scaled variables. The only variable with data missing from more than
five patients was chronic angina in which data was missing from 9 patients.
A multivariate logistic regression analysis was then performed in an effort to
determine which of the delay variables was significantly related to prolonged
delay independent of the others. The variables chosen for the multivariate
analysis are displayed in Table 11 and represent variables associated with delay
in previous studies, variables which showed a p-value of <.20 in the univariate
analysis, and the social isolation, cognitive impairment, and functional disability
variables which are unique to our study.
To determine if there was a significant relationship between prolonged delay
and outcome, a univariate analysis using the chi-square test was performed. A
multivariate analysis using the proportional hazards model was also conducted
to determine if prolonged delay was associated with increased 30-day and 1-year
mortality when controlling for other usual predictors of mortality after MI such
as age, sex, Killip class, type of MI, and systolic blood pressure on admission.

I
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Results

Study sample
The 183 persons in our study sample were compared with the 46 persons
without recorded delay times and no significant differences were found
regarding sociodemographic factors, past medical history, clinical presentation,
or outcome measures.
The background characteristics of the study participants are found in Table 10.
All subjects were at least 65 years old and 38% were aged 75 years or older. The
mean age was 78.0 years. Forty-five percent of the sample was female and 14%
were black.

Delay time
Delay time greater than 6 hours was recorded in 80 of the 183 (43.7%) study
participants.

Variables Related to Delay Time
The results of the univariate analysis in which the frequency of
sociodemographic factors, past medical history, and clinical presentation
variables were compared between early and late arrival groups is also found in
Table 10. Age was the only variable tested which was significantly related to
prolonged delay (pc.005). Four other variables, Killip class, CPK>4 times
normal, chest pain on admission, and atrial fibrillation on admission were
marginally related to prolonged delay (pc.10).
The results of the multivariate analysis of delay time variables are found in
Table 11. Killip class, older age, lack of visitation by a home care worker, and
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lower educational level were all independently predictive of prolonged delay
(p<.05).

Effect of Delay Time on Prognosis
Mortality at 30 days was 15.5% for persons who delayed <6 hours and 28.8%
for persons who delayed >6 hours. This difference is statistically significant
(p=.03). The difference in 1 year mortality seen in the two arrival groups (35% vs.
50%) was also significant (p=.04). There was no relationship between delay time
and several inhospital complications (Table 12).
A multivariate analysis of 30 day and 1 year mortality in which other
predictors of mortality after AMI were controlled for showed prolonged delay to
continue to predict increased mortality. The relative risk for 30 day and 1 year
mortality for persons who delayed more than 6 hours after AMI was found to be
2.1 (95% confidence interval 1.14 - 4.37) and 2.4 (95% confidence interval 1.41 4.09) respectively (Tables 13 and 14).

27

Discussion

A principal finding of this study is that measures of social isolation, cognitive
function, and functional disability were unable to predict prolonged delay in
elderly persons with AMI. It was hypothesized that these factors would partly
explain why delay time is increased in older persons. One measure of poor
functional status, home visitation by a health care worker, was significantly
related to delay time in a multivariate analysis. However, these persons were
actually less likely to exhibit prolonged delay than the rest of the study sample.
The reasons for this are unclear but may reflect a closer surveillance of the health
status of these persons and prompt encouragement to seek medical attention
when symptoms arise.
Other variables besides home visitation by a health care worker that were
found to be independently predictive of prolonged delay in a multivariate
analysis were lower Killip class, older age (75+), and lower educational level
(<12 years). Killip class and age have been associated with prolonged delay in
many previous studies (23,24,25,29,31,34,40,42). Educational level has been
associated with delay in only one previous study (42).
A second finding of this study was the association of prolonged delay after
AMI with increased 30-day and 1-year mortality. This increase in mortality
persisted even when controlling for usual predictors of mortality after AMI such
as Killup class, age, type of MI, gender, and systolic blood pressure on
admission. This finding is somewhat surprising considering that only 3 of 183
study participants received thrombolytic therapy. In the absence of thrombolytic
therapy, one must assume that much of the benefit of prompt hospital arrival
was provided by the earlier or more frequent administration of non-thrombolytic
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interventions such as nitroglycerin, beta-blockers, and aspirin. To the best of our
knowledge, this is the first study which has controlled for baseline risk factors
and still found an association between delay time and mortality in a population
which rarely received thrombolytic therapy.
The infrequent use of thrombolytics in this study was probably due to a
combination of factors including the typically low eligibility rates of the elderly,
reluctance on the part of physicians to use thrombolysis in the elderly, and the
fact that the study was conducted between 1982 and 1992 and that during much
of this time period thrombolytic therapy was not yet standard of care.
The finding that delay time is an independent predictor of mortality after AMI
in the elderly is important for two reasons. First, it is reassuring to know that
efforts to encourage prompt hospital arrival when experiencing symptoms of
AMI likely benefit all elderly persons with AMI, not the minority of elderly who
are eligible for and receive thrombolytic therapy. Second, our findings may
explain some of the observed association between older age and increased
mortality after AMI. Several studies of mortality after AMI have shown that age
per se remains a strong independent predictor of poor prognosis despite
extensive efforts to control for baseline characteristics, comorbid illnesses, and
therapeutic interventions (55-57). However, none of these studies have included
delay time in their analyses. Perhaps if delay time were included as a baseline
variable, the strength of the association between age and mortality after AMI
would diminish.
A limitation of our study is that it was restricted to persons with AMI who
presented to the emergency department. It did not include persons who died
prior to hospital arrival nor persons who survived the myocardial infarction but
did not come to the hospital despite symptoms or because their myocardial was
asymptomatic.
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Authers/Joumal

Study years

n

Confirmed M?

Mean age

%M

%B

Delay (mean, median)

Meischke at aL, 1995

1986-1987

2317

no

62

58

2

NA, 2
23%>6hrs

Annals of Emerg. Med (19)
Bl et al., 1994

1988-1990

448

no

NA

52

100

14.68,2.66

1986,1988.1990

1279

yes

NA

63

NA

4.0,2D

1989-1990

103

no

NA

NA

NA

49%>2 hrs, 21%>4

1987-1988

400

yes

NA

NA

NA

NA.3.5

1988-1989

3256

yes

56%>65

66

NA

NA, 2D

American J. of Pub. Health (20)
YarzebskietaL, 1994
American Heart Journal (21)
Heriotetaf., 1993
J. of Floyal Soc. of Med (22)
Logue et al., 1991
Annals of Emerg. Med (23)
Weaver etaL, 1991

28%>75

J. of Amer. ColL Cardiology (24)
Schmidt and Borsch, 1990

1988-1989

126

yes

58

75

NA

5.9,2D

NA

200

no

63

44

74

21

401 pre

no

63

56

NA

NA, 26

Amer. J. of Cardiology (25)
Clark etal., 1989
Circulation (26)
Ho etal., 1969

1986

Leitch, et al., 1999

NA, 23

489 post

Annals of Emerg. Med (27)
1987

100

no

NR

NA

NA

NA, 2D

1981-88

690

yes

NA

NA

NA

2.1, NA

1986

4102

no

NA

NA

NA

Med. J. of Australia (28)
Maynard et aL. 1989
Amer. J. Cardiology (29)
Ho etal., 1988
Circulation (30)
Rawles and Hakes, 1988

35% <2.21% 24,
44% >4 hrs

NR

450

yes

66.6

NA

NA

102

1986-1987

42

yes

NA

NA

NA

5D.2.0

1983-1984

111

yes

592

56

100

23,6

1978-1983

778

yes

NA

NA

NA

NA

1976-1977

1102

no

NA

64

14

NA, 2

1975

211

no

56

75

NA

7.5,3D

NA

107

yes

NA

NA

NA

NA, 2.75

NA

160

yes

NA

73

NA

NA.2.75

1970

75

no

NA

59

NA

NA, NA

1968-1969

160

yes

61

73

NA

NA, 3D

NA

100

no

NA

73

NA

10.6,4

1968

64

no

NA

73

NA

5, NA

British Med. Journal (31)
Wielgosz et aL. 1988
Canadian Med. Assoc. J. (32)
Cooper et aL, 1986
Amer. J. of Cardiology (33)

Turi etal., 1986
Amer. J. of Cardiology (34)
Alonzo, I960
Medical Care (35)
Shroederetal, 1978
Amer. J. of Medicine (36)
QiOum et al., 1976
Archives of Internal Med. (37)
Simon et aL, 1972
Amer. J. of Cardiology (38)
TjoeetaL, 1972
Chest (39)
Moss et aL, 1970
Circulation (40)
Hacked et al., 1989
Amer. J. of Cardiology (41)
Moss et aL, 1969
Amer. J. of Cardiology (42)

Table 1. Delay Times Reported in Previous'Studies
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Authora/Joumal

n

Older Aga Female Gender Blaok

Ell etal., 1994

448

No effect

No effect

1279

No effect

No effect

103

No effect

400

No effect

3256

Increased

126

increased

Increased

690

Increased

No effect

Increased Education Socioeconomic Statue

Increased No effect

No effect

Increased

No effect

Increased

No effect

No effect

No effect

No effect

American J. of Pub. Health (20)
Yarzebski etal., 1994
American Heart Journal (21)
Heriot et a!„ 1993
J. of Royal Soc. of Med. (22)
Logueetal., 1991
Annals of Emerg. Med. (23}
Weaver etal., 1991
J. of Amer. Coll. Cardiology (24)
Schmidt and Borsch, 1990
Amer. J. of Cardiology (25}
Maynard et al., 1989
Amer. J. Cardiology (29)
Schmidt et al„ 1989

126

Circulation (43)
Rawiesand Hates, 1988

450

increased

42

No effect

British Med. Journal (31)
Wielgosz et al., 1988
Canadian Med. Assoc. J. (32)
Cooper et al., 1986

111

Increased

Amer. J. of Cardiology (33)
Turi etal., 1986

778

Increased

increased

No effect

1102

No effect

Increased

Increased

Amer. J. of Cardiology (34}
Alonzo. 1980
Medical Care (35)
Shroeder etal., 1978

211

No effect

Amer. J. of Medicine (36)
Gillum etal., 1976

107

No effect

No effect

160

No effect

No effect

No effect

160

Increased

No effect

No effect

100

No effect

No effect

64

Increased

Increased

Archives of Internal Med. (37)
Simon etal., 1972
Amer. J. of Cardiology (38)
Moss etal., 1970
Circulation (40)
Hackett et al., 1969
Amer. J. of Cardiology (41)
Moss etal., 1969

Decreased

Amer. J. of Cardiology (42}

Table 2. Reported Effect of Sociodemographic Variables on Delay Time
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Authors/Joumal

n

M!

ElletaL, 1994

448

No effect No effect

1279

Increased No effect

Angina

chf

Diabetes Hypertension

Coronary Heart Disease

American J. of Pub. Health (20)
Yarzebski etal., 1994

Increased

No effect

No effect

Increased

American Heart Journal ^21)
Logue etal., 1991

400

No effect

126

No effect No effect

Annals of Emerg. Med. (23)
Schmidt and Borsch, 1990
Amer. J. of Cardiology (25)
Leiteh etal., 1989

No effect

100

MedJ. of Australia (28)
Maynard etal., 1989

690

No effect

Amer. J. Cardiology (29)
Rawtes and Haites, 1988

No effect

450

British Med. Journal (31)
Wielgosz et al., 1986

42

No effect No effect

778

No effect

Canadian Med. Assoc. J. (32)
TurietaJ., 1986

Increased Increased

Increased

Amer. J. of Cardiology (34)
Shroeder etal., 1978

211

Increased

Increased

Amer, J. of Medicine (36)
Gillum et al., 1976

107

No effect

Archives of Internal Med. (37)
Simon etal., 1972

160

No effect No effect

75

No effect

160

No effect Increased No effect Increased

100

No effect

64

No effect No effect No effect

Amer. J. of Cardiology (38)
Tjoeetal., 1972
Chest (39)
Moss etal., 1970

Decreased

Circulation (40)
Hackettetal., 1969
Amer. J. of Cardiology (41)
Moss etal., 1969

No effect

Amer. J. of Cardiology (42)

Table 3. Reported Effect of Past Medical History on Delay Time

No effect
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Authors/Journal

n

Patient alone Patient at home

YarzebskietaL, 1994

1279

Increased

No effect

Onset during day Onset during weekend
No effect

No effect

No effect

Decreased

American Heart Journal (21)
Schmidt and Borsch, 1990

No effect

126

Amer. J. of Cardiology (25)
Wielgoszetal., 1988

42

Canadian Med. Assoc. J. (32)
Turietal., 1986

778

Increased

Amer. J. of Cardiology (34)
Alonzo, 1986

1102

Decreased

Decreased

Soc. Sd. Med. (44)
Mossetal., 1970

160

Decreased

Circulation (40)
Hackett et al., 1969

100

Decreased

64

Decreased

Amer. J. of Cardiology (41)
Moss etal., 1969

Increased

Increased

Amer. J. of Cardiology (42)

Table 4. Reported Effect of Circumstances of AMI on Delay Time

Authors/Journal
Ell etal., 1994

n

Chest pain

Severe chest pain

Slowly progressive pain

Decreased

448

Amer. J. of Public Health (20)
Schmidt and Borsch, 1990

126

No effect

690

No effect

160

No effect

Decreased

Amer. J. of Cardiology (25)
Maynard etal., 1989
Amer. J. of Cardiology (29)
Mossetal., 1970
Circulation (40)
Hackett et al., 1969

100

Decreased

Amer. J. of Cardiology (41)

Table 5. Reported Effect of Symptoms of AMI on Delay Time

I

Increased

33

Authors/Jouma!

n

Yarzebski et aJ., 1994

1279

Hemodynamic Instability

Large Infarct

Q wave Ml
No effect

Amer. Heart Journal (21)
400

Logue et al., 1991

Decreased

Annals of Emergency Med. (23)
Schmidt and Borsch, 1990

Decreased

126

No effect

Amer. J. of Cardiology (25)
690

Maynard et al., 1989

Decreased

Amer. J. of Cardiology (29)
Leitch et a!., 1989

No effect

100

Med. J. of Australia (28)
Turietal., 1986

778

Decreased

Amer. J. of Cardiology (34)

Table 6. Reported Effect of Severity of AMI on Delay Time

Authors/Journal
Heriot eta!., 1993

n

103

Knowledge of benefits

Symptoms psrcsWsd

Knowledge ol

as cardiac

thrombolytlcs of early treatment

Decreased

Decreased

Exposure to public
educational campaign

Decreased

J. of Royal Soc. of Med. (22)
Btohmeta)., 1992

632

Decreased

American J. of Cardiology (45)
Schmidt and Borscht, 1990

126

No effect

200

Decreased

No effect

No effect

Amer. J. of Cardiology (25}
Clark et al., 1989
Circulation (26)
HoetaL, 1989

890

No effect

471

Decreased

Annals of Emerg. Med. (27)
Miticetal., 1934
Canadian J. of Pub. Health (46)
Hackettet al., 1969

100

Decreased

Amer. J. of Cardiolgy (41)

Table 7. Reported Effect of Medical Sophistication on Delay Time

34

Authors/Joumal

n

Self-medication

Ell et al.. 1994

448

Increased

Contacted MD Informed family member

Amer. J. of Public Health (20)
Heriot et al., 1993

Increased

102

J. of Royal Soc. of Med. (22)
Schmidt and Borsch, 1990

126

No effect

Increased

Amer. J. of Cardiology (25)
Leitch et al., 1989

100

Increased

42

Increased

Medical J. of Australia (28)
Weilgosz et al., 1988
Can. Med. Assoc. Journal (32)
Alonzo, 1986

1102

Increased

778

Increased

211

Increased

160

Increased

Increased

Increased

Soc. Sd Med. (44)
Turi et al., 1986
Amer. J. of Cardiology (34)
Schroederetal., 1978
Amer. J. of Medicine (36)
Simon et al., 1972
Cardiology (38)
Hacketetal., 1969

100

Amer. J. of Cardiology (41)

Table 8. Reported Effect of Patient Actions on Delay Time

Increased

35

Author*/Journal
Caggatal, 1001
Annals dlntamal Mad.

n
1144

Inckmion erttaria
pts hocpitaizad in Mchtgan hospital with verified
Ml but declared ineigWe
ter thrombotytics

% Thrombolyttes
0

Multivariate analysis
no significant effect of delay time on
inhospital mortality when controlling for
age. stroke or bleeding risk, gender, pre¬
vious Ml. location of Ml. duration of chest
pain, chronic angina. HTN, and peak
creatine kinase level

LoguaataL, 1981
Annals at Emorg Med.

400

consecutive pts *
midwest teaching
hospital with vented
AMI

18.5

persons arriving in <1.5 hours had
a significantly increased inhospital
mortality rate even when controlling for
age. previous Ml, chronic angina, and
Killip class

Maynard at aL. 1988
Amer. J. Cardiology

690

pis from 3 Washington
state thrombolytic trials
with verified Ml and
age <75; in 2 studies those
who delayed >6 hrs were
excluded and in one study
those who delayed >12 hrs
were excluded

62.6

no significant effect of delay time on 14day or 1-year mortality when controlling
for pulmonary edema, location of Ml,
hypotension, and chest pain

TuriataL, 1966
Amer. J. of Cardiology

778

pts wth verified Ml from
MIUS study who were
<76 years old and who
delayed <18 hours

0

no significant effect of delay time on
inhospital, 14-day, or 2-year mortality
when controlling for age. education,
previous Ml, gender, diabetes, and previous
OF

Table 9. Previous Multivariate Analyses of the Effect of Delay Time on Mortality
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All patients (%)

Variable

P value

Late Arrival Group (%)
(>6hours)

Early arrival group (%)
(<6 hours)

Soaodemographic
25

0.004

75
18.8
48.8
24.4
31.6

0.121
0.345
0.149
0.432

63.4
14.2
44.8
30
34.8

45.6
54.4
10.7
41.7
34.3
37.3

24.6

24.3

25

42
55.2

43.3
50.5

40.3
61.3

0.146

Diabetes mellitus

28.4

26.3

0.631

Of1

35
16.9
33
35.8
31.3
13.1

30.1
40
17.5
31.4
32.4
36.3
13.6

36.3
16.3
35.1
40.3
24.7
12.5

0.749
0.826
0.208

35.9
33
31.1
88.1
34

37.5
32.5
30
77.9
21.3

0.829

0.822
0.077

36.6

Age 65-74
75+
Black race
Female
Education >12 years
Married
Medical History
Myocardial infarction
Chronic angina
Hypertension

Current smoker
BMI <23
24-27
>28
CVA

0.91
0.686

0.828

Clinical Presentation
36.6
32.8
30.6
83.7

Systolic BP T1
T2
T3
Chest pain
CPK > 4X normal
Conduction disorder

28.3

0.068
0.059

13.1
13.7

12.6

13.8

Atrial fibrillation

9.7

Killup class

54.1

49.5
13.6
32
4.9

18.8
5
16.3
22.5
1.3

30.1
54.4

61.3

14.8

15.5

13.8

6.6
30

6 8
29.1

6.3
31.3

30
33.3
45.9

28.2
35.9
44.7

32.5
30
47.5

0.702

9.4
4.4

7.9

11.3
5

0.446
0.714

7.7

78.6
10.7

73.8

0.375

10.7

1 5

4.9
13.6

5
8.8

1

II
III
IV
Type of Ml - Q wave
norvQ

14.8
27.9
3.3
27.9
57.4

undetermined

25

0.056

0.641

Social Isolation
Social ties - zero
one
two
three+
Lives alone

0.621

Cognitive Function
Cognitive function impaired
Dementia
Functional ability
functional disability - zero

Previous nursing home
Home care worker visits

one

10.9

two

12.6
4.9
11.5

3.8

Table 10. Comparison of the Frequency of Delay Time Variables
in Early and Late Arrival Groups

11.3
0.964
0.308
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Variable
Higher Killip class
Home care worker visits
Older age (75+)
Education >12 years
CPK > 4X normal
Chest pain on admission
Black race
Functional Disability
Female
Atrial fibrillation on admission
Cognitive dysfunction
Systolic BP on admission
Q wave Ml
Social Ties
Live Alone

Odds Ratio

95% Confidence Interval

Standard Error

P value

0.2746
0.1837
2.4
0.4268
0.3948
0.385
2.2255
1.726
1.4752
1.6366
1.6305
0.8498
1.357
0.9427
0.9178

.1138 - .6629
.0454 - .7427
1.1585 * 4.9701
.1876 - .9711
.1549 • 1.006
.1367 - 1.084
.7902 - 6.268
.6549 - 4.546
.6950 - 3.1313
.5705 - 4.6950
.4787 - 5.5538
.5407 - 1.3357
.5425 - 3.3946
.6417 - 1,4143
.4286 - 1.9653

0.4496
0.7127
0.3715
0.4194
0.4774
0.5282
0.5283
0.4944
0.384
0.5377
0.6253
0.2307
0.4678
0.2016
0.3885

0.004
0.0174
0.0185
0.0423
0.0516
0.0708
0.1299
0.2695
0.3113
0.3596
0.4343
0.4807
0.514
0.8099
0.8252

Table 11. Multivariate Analysis of Variables Associated with Prolonged Delay
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Variable

All patients (%)

Early Arrival Group (%)
(<6 hours)

Inhospltal chest pain

33.5

Inhospital ischemia
Inhospltal relnfarctlon
Inhospltal CHF
30-day mortality
1-year mortality

16.5
6.8

0.634
0.845

31.6

35
16
4
18
15.5
35

20.5
21.3
41.5

P value

Late Arrival Group (%)
(>6 hours)
17.1
10.5

0.089
0.345

23.7
28.8
50

0.03
0.04

Table 12. Univariate Analysis of Delay Time and Outcome

Variable

Relative risk

95% Confidence Interval
3.327
2.237
2.096
1.054
0.584
0.518

Q wave Ml
Killip class
Delay > 6 hours
Older age (75+)
Female gender
Systolic BP on admission

1.728-6.405
1.114-4.374
1.006-4.124
1.003-1.108
.294-1.159
.338-.795

Table 13. Multivariate Analysis of Prolonged Delay and 30-Day Mortality

Variable
Killip class
Delay > 6 hours
Q wave Ml
CPK > 4X normal
Older age (75+)
Female gender
Systolic BP on admission

95% Confidence Interval

Relative risk
3.136
2.4
1.605
1.33
1.029
0.613
0.561

1.858
1.409
.817
.702
.992
.368
.702

Table 14. Multivariate Analysis of Prolonged Delay and 1-Year Mortality

-

5.293
4.087
3.155
2.520
1.068
1.024
2.520
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